Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1985 1
1986 1
1988 2
2004 1
2005 2
2008 1
2009 4
2010 1
2011 2
2012 1
2013 4
2014 2
2015 1
2018 2
2019 2
2020 2
2021 2
2022 1
2023 1
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
MANIFEST: Multiomic Platform for Cancer Immunotherapy.
Lim KHJ, Tippu Z, Corrie PG, Hubank M, Larkin J, Lawley TD, Stares M, Stewart GD, Strange A, Symeonides SN, Szabados B, Turner NC, Waddell T, Zelenay S, Salto-Tellez M, Dive C, Turajlic S; MANIFEST consortium. Lim KHJ, et al. Cancer Discov. 2025 May 2;15(5):878-883. doi: 10.1158/2159-8290.CD-25-0099. Cancer Discov. 2025. PMID: 40313120
What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study.
Rossi SH, Choueiri TK, Jewett M, Jones JO, Laird A, Lewis B, Tippu Z, Van Der Mijn JCK, Bex A, Stewart GD; International Neoadjuvant Kidney Cancer Consortium (INKCC) members. Rossi SH, et al. Ann Oncol. 2025 Oct;36(10):1231-1234. doi: 10.1016/j.annonc.2025.05.540. Epub 2025 Jun 4. Ann Oncol. 2025. PMID: 40480551 No abstract available.
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium.
Blackmur JP, van der Mijn JCK, Warren AY, Browning L, Burgers F, Hirsch MS, Kapur P, Mehra R, Rao P, Signoretti S, Bex A, Stewart GD, van Montfoort ML, Jones JO; International Neoadjuvant Kidney Cancer Consortium. Blackmur JP, et al. Lancet Oncol. 2025 Oct;26(10):e536-e546. doi: 10.1016/S1470-2045(25)00345-6. Lancet Oncol. 2025. PMID: 41038202 Review.
Virology. Frameshifting to PA-X influenza.
Yewdell JW, Ince WL. Yewdell JW, et al. Among authors: ince wl. Science. 2012 Jul 13;337(6091):164-5. doi: 10.1126/science.1225539. Science. 2012. PMID: 22798590 Free PMC article.
42 results